Legend Biotech Corporation Share

Legend Biotech Corporation (LEGN) is a global biotechnology company focused on the discovery, development, manufacturing, and commercialization of novel cell therapies for oncology and other indications. The company's primary focus is on developing innovative treatments for hematological malignancies, including multiple myeloma, a cancer of plasma cells. Legend Biotech leverages its expertise in cell engineering, immunotherapy, and manufacturing to create potentially transformative therapies for patients with unmet medical needs. The company's research and development efforts are centered on chimeric antigen receptor T-cell (CAR-T) therapies, which involve engineering a patient's own immune cells to recognize and attack cancer cells. Legend Biotech aims to improve patient outcomes and transform the treatment landscape for cancer and other serious diseases through its commitment to scientific innovation and clinical excellence.